Use of Rapid Diagnostic Tests for Malaria Case Management in Kenya
Introduction of Malaria Rapid Diagnostic Tests, Artemisinin-based Combination Therapy, and Malaria Case Management Guidelines at Health Facilities in Kenya: A Cluster Randomized Trial to Evaluate Adherence and Acceptance by Health Care Workers, Impact on Antimalarial Prescription Practices, and Patient Perceptions
Sponsor: Centers for Disease Control and Prevention
A NA clinical study on Malaria, this trial is completed. The trial is conducted by Centers for Disease Control and Prevention and has accumulated 5 data snapshots since 2006. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Jun 2018 — Jan 2021 [monthly]
Completed NA
-
Jan 2017 — Jun 2018 [monthly]
Completed NA
First recorded
Jul 2006
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Centers for Disease Control and Prevention
- KEMRI-Wellcome Trust Collaborative Research Program
- Kenya Division of Malaria Control
- Kenya Medical Research Institute
For direct contact, visit the study record on ClinicalTrials.gov .